Marc Peschanski
Overview
Explore the profile of Marc Peschanski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
2572
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Domingues S, Darle A, Masson Y, Saidani M, Lagoutte E, Bejanariu A, et al.
Cells
. 2022 Apr;
11(7).
PMID: 35406716
Chronic wounds, such as leg ulcers associated with sickle cell disease, occur as a consequence of a prolonged inflammatory phase during the healing process. They are extremely hard to heal...
2.
Peschanski M
Med Sci (Paris)
. 2021 Dec;
37 Hors série n° 2:13-14.
PMID: 34895451
No abstract available.
3.
Pourtoy-Brasselet S, Sciauvaud A, Boza-Moran M, Cailleret M, Jarrige M, Polveche H, et al.
Am J Hum Genet
. 2021 Oct;
108(11):2171-2185.
PMID: 34699745
Recent studies indicate that neurodegenerative processes that appear during childhood and adolescence in individuals with Wolfram syndrome (WS) occur in addition to early brain development alteration, which is clinically silent....
4.
Jarrige M, Polveche H, Carteron A, Janczarski S, Peschanski M, Auboeuf D, et al.
iScience
. 2021 Jul;
24(7):102767.
PMID: 34278269
Human pluripotent stem cells have ushered in an exciting new era for disease modeling, drug discovery, and cell therapy development. Continued progress toward realizing the potential of human pluripotent stem...
5.
Ruillier V, Tournois J, Boissart C, Lasbareilles M, Mahe G, Chatrousse L, et al.
JCI Insight
. 2020 Jan;
5(4).
PMID: 31990683
Lesch-Nyhan disease (LND) is a rare monogenic disease caused by deficiency of the salvage pathway enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRT). LND is characterized by severe neuropsychiatric symptoms that currently cannot be...
6.
Barrault L, Gide J, Qing T, Lesueur L, Tost J, Denis J, et al.
Cells
. 2019 Nov;
8(12).
PMID: 31779280
Substantial variations in differentiation properties have been reported among human pluripotent cell lines (hPSC), which could affect their utility and clinical safety. We characterized the variable osteogenic capacity observed between...
7.
Ben MBarek K, Bertin S, Brazhnikova E, Jaillard C, Habeler W, Plancheron A, et al.
Biomaterials
. 2019 Nov;
230:119603.
PMID: 31732225
Age-related macular degeneration as well as some forms of Retinitis Pigmentosa (RP) are characterized by a retinal degeneration involving the retinal pigment epithelium (RPE). Various strategies were proposed to cure...
8.
Georges P, Boza-Moran M, Gide J, Peche G, Foret B, Bayot A, et al.
Sci Rep
. 2019 Oct;
9(1):14568.
PMID: 31601825
Translation of pharmacological results from in vitro cell testing to clinical trials is challenging. One of the causes that may underlie these discrepant results is the lack of the phenotypic...
9.
Baghdoyan S, Bassez G, Audureau E, Peschanski M
Med Sci (Paris)
. 2019 Jan;
35(1):26-29.
PMID: 30672450
No abstract available.
10.
Maury Y, Poydenot P, Brinon B, Lesueur L, Gide J, Roqueviere S, et al.
iScience
. 2019 Jan;
11:258-271.
PMID: 30639849
There is currently no treatment for myotonic dystrophy type 1 (DM1), the most frequent myopathy of genetic origin. This progressive neuromuscular disease is caused by nuclear-retained RNAs containing expanded CUG...